We are excited to announce that Era Pharma a leading Pharmaceutical R&D company in Turkey and Shifa Holding a Pharma and Medicals company based in Qatar have completed the acquisition negotiation. This acquisition represents a significant milestone for our company, as we expand our capabilities and offerings in Türkiye and the region.

To commemorate this exciting acquisition, we held a ceremony on January 2023 at Doha/Qatar, where representatives from both companies gathered to celebrate the occasion. The event was attended by top executives from both companies.

During the ceremony, Era Pharma’s General Manager, Şirin Deha and CEO, Yusuf Alkhayyat, spoke about the strategic significance of the acquisition, highlighting the complementary strengths and capabilities of both companies. The management of Shifa Holding expressed their excitement about the opportunities that this acquisition would bring for the company and its employees.

The ceremony was a moment of celebration and reflection, as we looked back on the hard work and dedication that went into completing the acquisition. It was also a moment of excitement and anticipation, as we looked forward to the opportunities that this acquisition would bring for our company and our customers.

This acquisition is a testament to our commitment to growth and innovation. We are confident that by combining our strengths and capabilities, we can drive positive change and create value for our customers and stakeholders.

We would like to thank all our attendees, as well as our partners in Qatar, for their support and hospitality during this momentous occasion. We look forward to continuing to work together and to achieving great things in the years to come.